Repository logo
 

POSEIDON randomized phase II trial: Tamoxifen (TAM) plus taselisib or placebo (PLA) in patients (pts) with hormone receptor positive (HR+)/HER2-metastatic breast cancer (MBC)

Accepted version
Peer-reviewed

Type

Article

Change log

Authors

Oliveira, M 
Baird, RD 
Voorthuis, RAB 
De Boo, L 
van Rossum, AGJ 

Description

Keywords

32 Biomedical and Clinical Sciences, 3211 Oncology and Carcinogenesis, Clinical Trials and Supportive Activities, Clinical Research, Women's Health, Cancer, Breast Cancer, 6.1 Pharmaceuticals, Cancer

Journal Title

ANNALS OF ONCOLOGY

Conference Name

Journal ISSN

0923-7534
1569-8041

Volume Title

32

Publisher

Elsevier BV
Sponsorship
Cancer Research UK (C37096/A16673)